Conference Coverage

CBC values linked to CVD risk in psoriasis


 

REPORTING FROM IID 2018


“We aim to validate [the study results] with a Veterans Administration data set,” Dr. Conic said. If it pans out, “one use would be to send [patients with elevated values] to a cardiologist earlier” so other CVD risk factors can be monitored and treated. The findings also add to the case for good control, she noted.

Systemic inflammation is the common denominator between the blood value elevations and CVD. The same inflammatory cytokines that cause skin problems in psoriasis also stimulate bone marrow to release immature red blood cells, which are larger than mature cells, leading to an increased RDW. Similarly, elevated MPV indicates a higher number of larger, younger platelets in the blood.

“It’s probably something along those lines, but I think we need to go back to basic science and really figure it out,” Dr. Conic said.

Patients were 18-65 years old. The study excluded patients with diabetes, Crohn’s disease, RA, and generalized atherosclerosis.

The National Institutes of Health funded the work. Dr. Conic reported no relevant financial disclosures.

*This article was updated on May 30, 2018.

SOURCE: Conic R et al. IID 2018, Abstract 550.

Pages

Recommended Reading

Study highlights need to investigate psoriasis treatment outcomes in skin of color patients
Psoriatic Arthritis Resource Center
PASI responses with biologics similar among white, nonwhite individuals, study finds
Psoriatic Arthritis Resource Center
FDA approves IL-23 antagonist for plaque psoriasis
Psoriatic Arthritis Resource Center
FDA approves certolizumab label update for pregnancy, breastfeeding
Psoriatic Arthritis Resource Center
Study using U.K. data quantifies infection risk associated with psoriasis
Psoriatic Arthritis Resource Center
AbbVie, Samsung Bioepis settle suits with delayed U.S. entry for adalimumab biosimilar
Psoriatic Arthritis Resource Center
New PsA questionnaire fails to beat existing early screening methods
Psoriatic Arthritis Resource Center
How to avoid severe diarrhea from apremilast
Psoriatic Arthritis Resource Center
Is PASI 100 the new benchmark in psoriasis?
Psoriatic Arthritis Resource Center
Psoriasis duration reflects cardiovascular event risk
Psoriatic Arthritis Resource Center